Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Sell
14
BIVI Quote, Financials, Valuation and Earnings
Last price:
$0.88
Seasonality move
:
33.4%
Day range:
$0.82 - $0.88
52-week range:
$0.62 - $7.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.63x
Volume:
80K
Avg. volume:
189.9K
1-year change:
-83.31%
Market cap:
$15.1M
Revenue:
--
EPS (TTM):
-$3.46
BIVI Analysts' Consensus Rating
The 2 analysts providing 12-month price projections for BioVie shares anticipate an average target of $5.50, ranging from a low estimate of $5.00 to a high estimate of $6.00. This average target implies a growth of 572.62% compared to the current stock price of $0.82.
Consensus Price Target
$5.50
Highest Price Target
$6.00
Lowest Price Target
$5.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
BIVI Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
50
RGC alert for May 1
Regencell Bioscience Holdings [RGC] is up 21.25% over the past day.
Sell
38
WGS alert for May 1
GeneDx Holdings [WGS] is down 1.08% over the past day.
Sell
43
VICR alert for May 1
Vicor [VICR] is up 0.9% over the past day.
